523 related articles for article (PubMed ID: 22716295)
1. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007115. PubMed ID: 24385423
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
5. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Gaynor P; McCarberg B; Zheng W; Shoemaker S; Duenas H
Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
[TBL] [Abstract][Full Text] [Related]
6. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
Sun P; Zhao Y; Zhao Z; Bernauer M; Watson P
Pain Pract; 2012 Nov; 12(8):641-8. PubMed ID: 22335435
[TBL] [Abstract][Full Text] [Related]
7. [Duloxetine for chronic pain management: pharmacology and clinical use].
Masuda R; Itoh M; Suzuki T
Masui; 2013 Jul; 62(7):814-21. PubMed ID: 23905404
[TBL] [Abstract][Full Text] [Related]
8. ACP Journal Club. Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events.
Engel CC
Ann Intern Med; 2014 Apr; 160(8):JC12. PubMed ID: 24733217
[No Abstract] [Full Text] [Related]
9. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
10. A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
Gahimer J; Wernicke J; Yalcin I; Ossanna MJ; Wulster-Radcliffe M; Viktrup L
Curr Med Res Opin; 2007 Jan; 23(1):175-84. PubMed ID: 17257478
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine use in chronic painful conditions--individual patient data responder analysis.
Moore RA; Cai N; Skljarevski V; Tölle TR
Eur J Pain; 2014 Jan; 18(1):67-75. PubMed ID: 23733529
[TBL] [Abstract][Full Text] [Related]
12. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L
Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of duloxetine for chronic pain conditions.
Mease PJ; Walker DJ; Alaka K
Pain Manag; 2011 Mar; 1(2):159-70. PubMed ID: 24646356
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
Sultan A; Gaskell H; Derry S; Moore RA
BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
[TBL] [Abstract][Full Text] [Related]
17. Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.
Liu X; Cui Z; Niu L; Faries DE; Ball T; Johnstone B
Clin Ther; 2011 Nov; 33(11):1726-38. PubMed ID: 22019345
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
19. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
Sun P; Zhao Y; Zhao Z; Watson P
Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
Gao Y; Ning G; Jia WP; Zhou ZG; Xu ZR; Liu ZM; Liu C; Ma JH; Li Q; Cheng LL; Wen CY; Zhang SY; Zhang Q; Desaiah D; Skljarevski V
Chin Med J (Engl); 2010 Nov; 123(22):3184-92. PubMed ID: 21163113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]